CC
Chris Cooley Stephens & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Vericel Corp
VCEL
$1.65B
| $32.77 | $42 |
28%
upside
| Overweight |
11 May ‘23
2 years ago |
|
2
Align Technology
ALGN
$10.1B
| $138.75 | $375 |
170%
upside
| Overweight |
28 Jul ‘22
3 years ago |
|
3
Cooper Companies
COO
$13.5B
| $67.93 | $115 |
69%
upside
| Overweight |
3 Jun ‘22
3 years ago |
|
4
Alcon
ALC
$39B
| $78.91 | $92 |
17%
upside
| Overweight |
12 May ‘22
3 years ago |
|
5
Pulse Biosciences
PLSE
$1.02B
| $15.09 | $12 |
20%
downside
| Overweight |
1 Apr ‘22
3 years ago |
|
6
Establishment Labs
ESTA
$1.1B
| $38.12 | $90 |
136%
upside
| Overweight |
10 Nov ‘21
3 years ago |
|
7
Steris
STE
$24.3B
| $247.19 | $270 |
9%
upside
| Overweight |
4 Nov ‘21
3 years ago |
|
8
Glaukos
GKOS
$5.21B
| $90.78 | $68 |
25%
downside
| Overweight |
3 Nov ‘21
3 years ago |
|
9
Avanos Medical
AVNS
$573M
| $12.35 | $45 |
264%
upside
| Equal-Weight |
4 Aug ‘21
4 years ago |
|
10
Teleflex
TFX
$5.76B
| $130.24 | $275 |
111%
upside
| Overweight |
23 Mar ‘20
5 years ago |
|
11
STAAR Surgical
STAA
$1.38B
| $27.85 | $37 |
33%
upside
| Overweight |
23 Mar ‘20
5 years ago |
|
12
DexCom
DXCM
$30.7B
| $78.26 | $60 |
23%
downside
| Overweight |
23 Mar ‘20
5 years ago |
|
13
Boston Scientific
BSX
$161B
| $108.41 | $35 |
68%
downside
| Overweight |
23 Mar ‘20
5 years ago |
|